Acne Drugs Market Growth 2023 | Industry Trends, Share, Size and Forecast 2028

The global acne drugs market size reached US$ 6.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2023-2028.

IMARC Group, a leading market research company, has recently releases report titled, “Acne Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The study provides a detailed analysis of the industry, including the global acne drugs market growth, share, size and trends forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the acne drugs market?

Report AttributesDetails
Market Size in 2022US$ 6.5 Billion
Market Forecast in 2028US$ 9.2 Billion
Growth rate (2023 to 2028)CAGR of 5.3%
Base Year of the Analysis2022
Forecast Period2023-2028

What is acne drugs?

Acne is a prevalent skin condition that occurs when hair follicles become clogged with oil and dead skin cells, resulting in the formation of whiteheads, blackheads, lumps, and pimples. It encompasses both non-inflammatory and inflammatory types, which can potentially lead to permanent scarring. Acne can be triggered by factors such as hormonal changes during menstruation, an unhealthy diet, emotional stress, hot and humid climates, and the use of allergenic cosmetics. Various treatment options are available to address acne, including prescription medications and over-the-counter (OTC) drugs like retinoids, antibiotics, salicylic acid, benzoyl peroxide, and oral contraceptives, which can effectively alleviate symptoms and promote healing.

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/acne-drugs-market/requestsample

What are the growth prospects and trends in the acne drugs industry?

The acne drugs market is experiencing significant growth due to the increasing prevalence of skin conditions among teenagers and adults worldwide. Consumers are becoming more aware of the wide range of acne products and treatment options available, which is contributing to a positive market outlook. Additionally, the development of effective acne drugs with minimal side effects and high efficacy is driving market growth. The availability of these acne drugs through various distribution channels, including pharmacies, drugstores, and online stores, presents promising opportunities for industry investors. Moreover, key manufacturers are introducing isotretinoin capsules, specifically designed for patients with severe nodular acne, further fueling the market's expansion.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Acne Type:

  • Comedonal
  • Inflammatory
  • Cystic
  • Postsurgical/Wound

Breakup by Drug Class:

  • Retinoids
  • Antibiotics
  • Hormonal Agents
  • Combination Drugs
  • Others

Breakup by Drug Type:

  • OTC Drugs
  • Prescription Drugs

Breakup by Route of Administration:

  • Topical
  • Oral
  • Injectable

Breakup by Region:

  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Allergan Plc
  • Bausch Health Companies Inc.
  • Bayer Aktiengesellschaft
  • Cipher Pharmaceuticals Inc.
  • Galderma Holding SA
  • Johnson & Johnson
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • Skinvisible Pharmaceuticals Inc.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=2359&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group


Marcel Mikaelson

29 Blog posts

Comments